Sleep apnea’s contribution to diabetic nephropathy needs attention

The effect of obstructive sleep apnea syndrome (OSAS) on the development of diabetic nephropathy requires investigation, say researchers.

In diabetes patients, OSAS has unfavorable outcomes due to its negative effect on glucose regulation and should be screened for in patients with diabetes, especially if they are obese, they say.

In addition, large studies should be carried out to establish the interrelation between OSAS and diabetic nephropathy.

"Renal failure progression can be worsened with the presence of OSAS," explain Banu Buyukaydin (Bezmialem Vakif University Faculty of Medicine, Istanbul, Turkey) and colleagues. "In these patients, intermittent hypoxia increases sympathetic activation and inflammatory cytokines but there are few studies concerning the relationship between these two clinical pathologies."

In their assessment of 52 obese patients (mean body mass index 32.4 kg/m2) with Type 2 diabetes and sleeping complaints including snoring and shortness of breath, the researchers found that 37 (71.2%) individuals had microalbuminuria (up to 300 mg/day).

Evaluation of the patients' polysomnography findings according to criteria from the American Academy of Sleep Medicine revealed that 35 (67.3%) had OSAS, defined as a score of 5 or more on the apnea hypopnea index (AHI).

Twenty-five (48%) of the patients had mild OSAS (AHI score 5‑15), six (11.5%) had OSAS to a moderate degree (AHI 15‑30), and four (7.7%) had severe OSAS (AHI ≥30).

As reported in Diabetes Research and Clinical Practice, there was no significant relationship between urinary albumin excretion and all apnea indices, all hypopnea indices, oxygen desaturation indices, mean nocturnal oxygen levels, or duration of sleep time below saturation 90%.

The team points out, however, that the study sample was small and most of the patients had been treated with renin-angiotensin aldosterone system blockers, which have established favorable effects on nephropathy development.

The expected relationship between the two clinical pathologies needs to be investigated in large populations of patients with diabetes, say Buyukaydin et al.

"OSAS and glucose intolerance are interacting pathologies but the effect of OSAS on nephropathy development in Type 2 [diabetes mellitus] patients is an important clinical process that should be investigated," concludes the team.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2020, April 03). Sleep apnea’s contribution to diabetic nephropathy needs attention. News-Medical. Retrieved on August 07, 2022 from

  • MLA

    Robertson, Sally. "Sleep apnea’s contribution to diabetic nephropathy needs attention". News-Medical. 07 August 2022. <>.

  • Chicago

    Robertson, Sally. "Sleep apnea’s contribution to diabetic nephropathy needs attention". News-Medical. (accessed August 07, 2022).

  • Harvard

    Robertson, Sally. 2020. Sleep apnea’s contribution to diabetic nephropathy needs attention. News-Medical, viewed 07 August 2022,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Researchers evaluate the brain circuits involved in social defeat stress-induced sleep in mice